Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2023 Oct 1;12(5):736-739.
doi: 10.21037/hbsn-23-310. Epub 2023 Sep 18.

Utility of circulating tumor DNA in patients undergoing hepatectomy for colorectal liver metastases

Philippine Cnockaert  1 , Fabrice Muscari  1 , Charlotte Maulat  1
Affiliations
Editorial

Utility of circulating tumor DNA in patients undergoing hepatectomy for colorectal liver metastases

Philippine Cnockaert et al. Hepatobiliary Surg Nutr. .
No abstract available

Keywords: Circulating tumor DNA (ctDNA); colorectal liver metastases (CRLM); hepatectomy; somatic mutations; survival.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at https://hbsn.amegroups.com/article/view/10.21037/hbsn-23-310/coif). The authors have no conflicts of interest to declare.

Comment on

References

    1. Newhook TE, Overman MJ, Chun YS, et al. Prospective Study of Perioperative Circulating Tumor DNA Dynamics in Patients Undergoing Hepatectomy for Colorectal Liver Metastases. Ann Surg 2022. [Epub ahead of print]. doi: .10.1097/SLA.0000000000005461 - DOI - PMC - PubMed
    1. Bolhuis K, van 't Erve I, Mijnals C, et al. Postoperative circulating tumour DNA is associated with pathologic response and recurrence-free survival after resection of colorectal cancer liver metastases. EBioMedicine 2021;70:103498. 10.1016/j.ebiom.2021.103498 - DOI - PMC - PubMed
    1. Wang DS, Yang H, Liu XY, et al. Dynamic monitoring of circulating tumor DNA to predict prognosis and efficacy of adjuvant chemotherapy after resection of colorectal liver metastases. Theranostics 2021;11:7018-28. 10.7150/thno.59644 - DOI - PMC - PubMed
    1. Tie J, Cohen JD, Wang Y, et al. Circulating Tumor DNA Analyses as Markers of Recurrence Risk and Benefit of Adjuvant Therapy for Stage III Colon Cancer. JAMA Oncol 2019;5:1710-7. 10.1001/jamaoncol.2019.3616 - DOI - PMC - PubMed
    1. Wang R, Zhao A, Cao N, et al. The value of circulation tumor DNA in predicting postoperative recurrence of colorectal cancer: a meta-analysis. Int J Colorectal Dis 2020;35:1463-75. 10.1007/s00384-020-03667-y - DOI - PubMed